grant

Cancer Genetic Markers of Susceptibility

Organization DIVISION OF CANCER EPIDEMIOLOGY AND GENETICSLocation UNITED STATES
NIHUS FederalResearch GrantFY2025AccelerationBladder CancerBrain NeoplasiaBrain NeoplasmsBrain TumorsBreast CancerCancer TreatmentCancersCarcinogenesis MechanismCessation of lifeColorectal CancerDeathEarly DiagnosisEndometrial CancerEndometrial CarcinomaEndometrium CancerEndometrium CarcinomaGene x Environment InteractionGenesGenetic MarkersGenetic ResearchGenome ScanGenomicsGoalsGxE interactionHereditaryHuman GeneticsInheritedInvestigatorsKidney CancerKidney CarcinomaMalignant Bladder NeoplasmMalignant Breast NeoplasmMalignant Neoplasm TherapyMalignant Neoplasm TreatmentMalignant NeoplasmsMalignant Ovarian NeoplasmMalignant Ovarian TumorMalignant TumorMalignant Tumor of the BladderMalignant Tumor of the LungMalignant Tumor of the OvaryMalignant neoplasm of lungMalignant neoplasm of ovaryMalignant neoplasm of prostateMalignant neoplasm of urinary bladderMalignant prostatic tumorNon-Hodgkin's LymphomaNonhodgkins LymphomaOvary CancerPredispositionPredisposition genePreventionProstate CAProstate CancerProstate malignancyPulmonary CancerPulmonary malignant NeoplasmRenal CancerRenal CarcinomaResearch PersonnelResearchersSingle Base PolymorphismSingle Nucleotide PolymorphismSusceptibilitySusceptibility GeneTechnologyUrinary Bladder CancerUrinary Bladder Malignant TumorVariantVariationWorkanti-cancer therapybreast cancer progressioncancer geneticscancer riskcancer therapycancer-directed therapyearly detectionenvironment effect on genegene biomarkergene environment interactiongene expression biomarkergene markergene signature biomarkergenetic biomarkergenome-wide scangenomewide scanhuman genome sequencinginsightlung cancermalignancymalignant breast tumormeetingmeetingsneoplasm/cancernew approachesnew technologynon-Hodgkins diseasenovel approachesnovel strategiesnovel strategynovel technologiesovarian cancerpredisposing genesingle nucleotide variantsusceptibility allelesusceptibility locussusceptibility varianttooltumors in the brainwhole-genome scan
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

To help meet the Challenge Goal of eliminating suffering and death from cancer by 2015, the NCI must capitalize on the extraordinary momentum generated by advances in human genetic research. The sequencing of the human genome and the annotation of common variations, together with new technologies for analyzing single nucleotide polymorphisms…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Cancer Genetic Markers of Susceptibility — DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS | UNITED STATES | Dev Procure